Medicinal Genomics is a leading brand in the field of cannabis genetics and microbial detection. They specialize in offering DNA sequencing and metagenomics services for cannabis products. Their expertise in genomics allows them to improve the yield, safety, and quality of medicinal plants through breeding, testing, and research.

Led by their founder and CSO, Kevin McKernan, who was previously involved in the Human Genome Project at MIT, Medicinal Genomics utilizes the most advanced and exacting tool of genomics science to understand the genetic characteristics of phyto-medicinals. They believe in the healing power of plants and strive to provide medicine grounded in research and proven by rigorous science. With a team of passionate scientists, clinicians, and cultivators, Medicinal Genomics aims to build a new world of plant-based medicine based on genomics and rigorous scientific discipline